UNSPSC 51343303: Memotine

This classification denotes an antiviral agent with the molecular formula C17H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42BHH3WP14, chemically known as 1-[(4-methoxyphenoxy)methyl]-3,4-dihydroisoquinoline but generally known as memotine, which bears US NIH Compound Identifier 25350. Most nations schedule memotine under HS 29334990 and SITC 51575. As of Q4 2014, MEMOTINE remains the US FDA Preferred Term for this commodity. Memotine bears US NLM identifiers UMLS ID C2981324 and NCI Concept Code C87664.

SMILES: COC1=CC=C(C=C1)OCC2=NCCC3=CC=CC=C32.

UNSPSC 51343303 Memotine is a Commodity code covering pharmaceutical and medical supply procurement by state and local government bodies, though recent opportunities tagged under this code show significant scope divergence. State and local governments are actively soliciting naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and direct-to-manufacturer prescription programs. Issuing bodies span county health departments, municipal fire departments, state health and human services commissions, and multistate cooperative purchasing alliances. The Seminole County, Florida procurement (IFB 60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. The City of Tampa (IFB 26P00145, due March 13, 2026) issued a sealed-bid solicitation for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent bid discount sheltered for certified Small Local Business Enterprises. The Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) sought vendor capabilities for a direct-to-manufacturer prescription program operating outside traditional pharmacy benefit manager arrangements.

Recent activity concentrates in Florida and Texas, with multistate cooperative purchasing also prominent. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, requiring manufacturers to supply through three authorized wholesalers and submit detailed NDC and product information. The Tampa and Seminole County opportunities both required F.O.B. delivery within specified timeframes and full shipping-cost inclusion in pricing. MMCAP's procurement imposed cGMP and Drug Supply Chain Security Act compliance, $5 million commercial general liability insurance, and a 3 percent administrative fee on all purchases. The code shows active state and local demand for pharmaceutical, naloxone, and emergency medical supplies, with cooperative purchasing vehicles and set-aside opportunities available in some jurisdictions.